US Archives - Page 54 of 157 - European Medical Journal

AMJ Oncology 2.1 2025

Explore the latest issue of AMJ Oncology, featuring expert insights from American Society of Clinical Oncology (ASCO) 2025, new research…

Neoadjuvant Therapy in TNBC: Current Landscape and Emerging Therapies

Triple-negative breast cancer (TNBC) comprises 10–15% of all breast cancers. It is a very heterogeneous disease, characterized by the…

The latest edition of AMJ Oncology

Uncover everything you need to know from this year’s ASCO congress and beyond in our new Oncology journal, featuring the latest highlights…

American Society of Clinical Oncology (ASCO) Annual Meeting 2025 Highlights

Optimizing Board Exam Outcomes For Hematology/Oncology Fellows

Certification in Hematology and Oncology requires mastery of increasingly complex clinical knowledge. Despite this, approximately 8% of…

ASCO 2025: Driving Knowledge to Action in Cancer Care

THE 2025 American Society of Clinical Oncology (ASCO) Annual Meeting underscored a key principle: in today’s complex and rapidly…

Current Approaches to Recurrent and Metastatic Cervical Cancer

Despite improved screening and treatment in developing nations, cervical cancer continues to have a global incidence of approximately…

Novel Pharmacology Curriculum in Hematology-Oncology Fellowship Program

Thorough understanding of cancer therapeutics is a critical component of hematology–oncology (HO) training, with pharmacology…

ASCO 2025: Highlights in Breast Cancer Research

THE theme of this year’s American Society of Clinical Oncology (ASCO) Annual Meeting was ‘Driving Knowledge to Action: Building a Better…

High-Grade Gallbladder Neuroendocrine Tumor in a Young Female

Neuroendocrine tumors (NET) constitute a heterogeneous group of neoplasms that originate from cells of the diffuse neuroendocrine system…